,9,10,11,12,13 In the present review, we focus on papers that specifically use PET for the measurement of Aβ and tau in humans, restricting our discussion to evidence highly relevant and translatable to the clinical manifestation of AD. The gene discussed is MAPT; the disease is Alzheimer disease.